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Renal function and blood pressure (BP) exhibit a circadian pattern of variation, but the
molecular mechanism underlying this circadian regulation is not fully understood. We
have previously shown that the circadian clock protein Per1 positively regulates the basal
and aldosterone-mediated expression of the alpha subunit of the renal epithelial sodium
channel (αENaC). The mechanism of this regulation has not been determined however.
To further elucidate the mechanism of mineralocorticoid receptor (MR) and Per1 action,
site-directed mutagenesis, DNA pull-down assays and chromatin immunoprecipitation
(ChIP) methods were used to investigate the coordinate regulation of αENaC by Per1
and MR. Mutation of two circadian response E-boxes in the human αENaC promoter
abolished both basal and aldosterone-mediated promoter activity. DNA pull down assays
demonstrated the interaction of both MR and Per1 with the E-boxes from the αENaC
promoter. These observations were corroborated by ChIP experiments showing increased
occupancy of MR and Per1 on an E-box of the αENaC promoter in the presence of
aldosterone. This is the first report of an aldosterone-mediated increase in Per1 on a target
gene promoter. Taken together, these results demonstrate the novel finding that Per1 and
MR mediate the aldosterone response of αENaC through DNA/protein interaction in renal
collecting duct cells.
Keywords: kidney, ENaC, E-box, MR, circadian clock
INTRODUCTION
The circadian clock regulates the rhythmic fluctuation of physio-
logical processes, including but not limited to: immune, repro-
ductive, vascular, endocrine, blood pressure (BP), and renal
function (Lowrey and Takahashi, 2004; Agarwal, 2010; Stow and
Gumz, 2011; Richards and Gumz, 2012). The mammalian clock
can be divided into two components: the central circadian clock
located in the suprachiasmatic nuclei in the hypothalamus of
the brain, which synchronizes itself in response to light, and the
peripheral clocks that exist in almost every organ and tissue. The
entrainment of the peripheral clock occurs via mechanisms that
are thought to act both independently and dependently of the
central clock (Dibner et al., 2010; Richards and Gumz, 2012).
At the molecular level, the circadian clock mechanism is regu-
lated by a transcription and translation oscillating loop, which
consists of four core circadian proteins. The heterodimer of the
transcription factors circadian locomotor output cycles kaput
(CLOCK) and brain and muscle ARNT (aryl hydrocarbon recep-
tor nuclear translocator)-like 1 (BMAL1) stimulate gene tran-
scription by binding to response elements (E-boxes) present in
the clock-controlled gene promoters. Among the genes activated
by CLOCK and BMAL1 are their own repressors encoded in the
Period (Per1, Per2, and Per3) and Cryptochrome (Cry1 and Cry2)
genes (Albrecht and Eichele, 2003). In each peripheral organ,
the circadian clock drives rhythmic expression of thousands of
genes through interaction with the E-box response elements.
Recent evidence suggests novel mechanisms of circadian regula-
tion including the interaction of the circadian clock proteins with
nuclear receptors and the existence of co-regulatory mechanisms
(Lamia et al., 2011) [reviewed in Richards and Gumz (2013)].
Profiling experiments demonstrated that a multitude of nuclear
receptors were shown to exhibit rhythmic oscillations in adipose,
liver, and muscle tissue (Yang et al., 2006).
Aldosterone is a mineralocorticoid steroid hormone involved
in regulation of sodium reabsorption and BP control. Aldosterone
action is primarily mediated via the mineralocorticoid receptor
(MR). Plasma aldosterone levels fluctuate with a circadian pattern
in humans and mice (Agarwal, 2010; Nikolaeva et al., 2012). The
molecular connection between aldosterone action and the cir-
cadian clock remains largely unknown. However, previous work
from our lab demonstrated that the circadian protein Per1 is an
early aldosterone target (Gumz et al., 2003).
αENaC is the regulated subunit of the renal epithelial sodium
channel (ENaC) (Palmer et al., 2012). The circadian protein Per1
positively regulates the basal transcription and the aldosterone-
induction of the Scnn1a (hereafter referred to as αENaC) gene
(Gumz et al., 2009, 2010). This regulation occurs through
interactions with an E-box element located in the promoter.
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Pharmacological blockade of Per1 translocation into the nucleus
prevents Per1 from interacting with promoter E-box resulting
in reduced basal level and aldosterone-mediated induction of
αENaC, and decreased ENaC activity (Richards et al., 2012).
Per1 also coordinately regulates multiple other genes involved
in sodium reabsorption in the kidney (Stow et al., 2012). This
regulation includes the positive regulation of Fxyd5, a positive
regulator of the Na,K-ATPase (Lubarski et al., 2005), and the neg-
ative regulation of Endothelin-1 and Caveolin-1. Endothelin-1
is a potent inhibitor of ENaC channel activity through both the
Endothelin-A and Endothelin-B receptors via a nitric-oxide
dependent mechanism (Bugaj et al., 2008; Lynch et al., 2013).
Caveolin-1 is a lipid raft protein, which retrieves ENaC from the
membrane (Lee et al., 2009). The regulation of these genes by Per1
predicts that loss of Per1 should result in renal sodium wasting,
decreased plasma volume, and subsequent decreased BP. Indeed,
we have shown that Per1 KO mice have lower BP compared to
wild type (WT) mice (Stow et al., 2012).
Since Per1 regulates the basal and the aldosterone-mediated
regulation of αENaC (Gumz et al., 2009, 2010; Richards et al.,
2012), we hypothesized that Per1 and MR may act coordinately
on αENaC expression during the aldosterone response. Here
we report the presence of Per1 and MR at the E-box response
elements from the αENaC promoter in the renal cortical col-
lecting duct cell line mpkCCDc14. Mutations of the E-boxes
in the human promoter abolished both basal and aldosterone-
mediated promoter activity. DNA pull down assays demonstrated
the interaction of both MR and Per1 with a specific E-box
from the promoter. These interactions were confirmed on the
endogenous αENaC promoter using chromatin immunoprecip-
itation (ChIP). Taken together, these results demonstrate coor-
dinate regulation of αENaC expression by Per1 and MR during
the aldosterone response and demonstrate a potential mecha-
nism for αENaC gene regulation by MR and a circadian clock
protein.
MATERIALS AND METHODS
CELL CULTURE AND HORMONE TREATMENT
The mpkCCDc14 cells were a gift from Dr. Alain Vandewalle
(INSERM, Paris, France) (Bens et al., 1999). All cells were main-
tained in DMEM/F-12 (Invitrogen) plus 10% fetal bovine serum
(FBS) and 50μg/ml gentamicin (Sigma).
CONSTRUCTION OF E-box MUTATIONS IN THE αENaC PROMOTER
Mutations of the αENaC promoter-luciferase construct were
made using QuikChange® Site-Directed Mutagenesis Kit
(Stratagene) according to the manufacturer’s instructions.
Specific primers were used to mutate putative E-boxes in the
αENaC promoter, creating new restriction sites that were ver-
ified by both restriction enzyme digests and DNA sequencing
(Table 1). The human promoter was analyzed for putative
E-box motifs using TF Search (http://www.cbrc.jp/research/db/
TFSEARCH.html) as described (Gumz et al., 2010).
LUCIFERASE ASSAYS
Approximately 192,000 mpkCCDc14 cells were seeded in 24-well
plates (Corning). Twenty-four hours later cells were transfected
with pGL3 (Promega), a human αENaC promoter-luciferase
construct (gift of Dr. Christie Thomas, University of Iowa),
or a mutated promoter-luciferase construct. Transfections were
performed using lipofectamine (Invitrogen), according to the
manufacturer’s instructions, in serum-depleted media. 1μM
Aldosterone or vehicle (ethanol) treatment was administered 24 h
later. Final ethanol concentration in both vehicle and aldos-
terone treated cells was 0.1%. All cells were co-transfected with
equal amounts of the plasmid pRL-TK (Promega). Transfection
efficiency was normalized to Renilla luciferase levels. Dual-
luciferase assays (Promega) were performed according to the
manufacturer’s instructions.
NUCLEAR EXTRACTS, DNA AFFINITY PURIFICATION ASSAYS (DAPA),
AND IMMUNOBLOTTING
Nuclear and cytosolic extracts were isolated using the NE-PER
kit (Pierce) according to the manufacturer’s instructions. For
DNA affinity purification assay (DAPA), Probes were immobi-
lized on 50μl of streptavidin-coated agarose beads (Sigma) and
incubated with 175μg of nuclear mpkCCDc14 extracts either
treated with vehicle (ethanol) or 1μM aldosterone for 24 h in
the presence of freshly prepared protease inhibitors (Fischer)
for 2 h at 4◦C with end-over-end rotation. Beads were pel-
leted. Supernatants were removed and used for input controls
by Western blotting for actin. Pelleted beads were washed four
times with ice-cold PBS plus protease inhibitors. After the
final wash, all liquid was aspirated from the beads with flat-
headed gel loading tips. Then 50μl of Laemmli sample buffer
(Invitrogen) plus β-mercaptoethanol was added and samples
were boiled for 5min, chilled on ice, and loaded onto a BioRad
4–20% Mini-PROTEAN® TGX™ Precast Gel for electrophore-
sis. Samples were then transferred to a polyvinylidene fluoride
(PVDF) membrane. The membrane was blocked in 2% non-
fat dry milk in TBS-S [Tris-buffered saline (TBS) plus 0.05%
Rodeo™ Saddle Soap] (USB) and incubated overnight at 4◦C
with anti-CLOCK (1:1000) (Pierce), anti-Per1 (1:500) (Pierce),
anti-rMR1-18 1D5 (anti-MR) (1:500) (DSHB), or anti-actin
(1:500) (Santa Cruz) antibodies. The rMR1-18 1D5 developed
by Dr. Gomez-Sanchez was obtained from the Developmental
Table 1 | Mutation of E-boxes in αENaC promoter-luciferase construct.
Plasmid mE-box 1 mE-box 2
E-box sequence ATCCAGCTGTCC CTTCACCTGGGC
Mutated sequence ATCCAGCTAGCC CGGTACCTGGGC
Forward primer 5′CAATGAAGAAAAATCCAGCTAGCCCTTCCAAGGGGAGGTATC 5′CGCCTAGCCCCCAGCGGTACCTGGGCCCCTCCC
Reverse primer 5′GATACCTCCCCTTGGAAGGGCTAGCTGGATTTTTCTTCATTG 5′GGGAGGGGCCCAGGTACCGCTGGGGGCTAGGCG
New restriction digest site Nhe1 Kpn1
Frontiers in Physiology | Integrative Physiology September 2013 | Volume 4 | Article 253 | 2
Richards et al. Per1 and MR in the coordinate regulation of αENaC
Studies Hybridoma Bank developed under the auspices of the
NICHD and maintained by the University of Iowa, Department
of Biology, Iowa City, IA 52242. The membrane was washed with
2% non-fat dry milk in TBS-S for 15min and then incubated
with horseradish peroxidase conjugate anti-rabbit secondary
antibody or anti-mouse secondary antibody (for anti-MR) and
incubated in 2% non-fat dry milk in TBS-S for 1 h at 4◦C.
After incubation, the blot was washed with TBS-S for 15min.
Detection was performed using Novex® ECL Chemiluminescent
Substrate reagents (Invitrogen). The sequences of the DAPA
probes were (E-box sequence is underlined): wild-type human
E-box 1 (5′CAATGAAGAAAAATCCAGCTGTCCCTTCCAAGG
GGA), mutated -human E-box 1 (5′CAATGAAGAAAAATC
CAGCTAGCCCTTCCAAGGGGA), wild-type human E-box
2 (5′CCTAGCCCCCAGCTTCACCTGGGCCCCTCCCGGGTC),
and mutated human E-box 2 (5′CCTAGCCCCCAGCGGT
ACCTGGGCCCCTCCCGGGTC).
CHROMATIN IMMUNOPRECIPITATION (ChIP)
The mpkCCDc14 cells were grown to ∼80% confluency and
then treated with vehicle (ethanol) or 1μM aldosterone
for 24 h. ChIP was performed using the ChIP-ITtm Express
Enzymatic Kit (Active Motif) according to the manufac-
turer’s instructions. Chromatin concentrations were calculated
and equal amounts of vehicle-treated and 1μM aldosterone
chromatin were used per pull down. Pull downs were per-
formed using 3μg of either anti-Per1 (Pierce), anti-rMR1-18
1D5 (anti-MR) (DSHB, Iowa), anti-Pol II (Santa Cruz),
or rabbit IgG (Bethyl) and were incubated overnight at
4◦C with end-over-end rotation. Immunoprecipitated DNA
was amplified by End Point PCR with primer pairs that
flanked the previously identified Per1 binding E-box (Gumz
et al., 2010). (Forward 5′ATTCCTGGCCTATCAGCCAA)
(Reverse 5′AAAGAGAATGGGTCCCCCAA). Band inten-
sities were quantitated using densitometry, which was
performed using ImageJ (rsbweb.nih.gov/ij). Bands were
relativized to the relevant vehicle or aldosterone-treated 10%
input.
STATISTICS
All experiments, unless otherwise stated, were performed in
duplicate in at least three independent studies. Two-tailed stu-
dent’s unpaired t-test (Microsoft Excel) was used to test statistical
significance and p < 0.05 was considered significant. Data are
presented as the means ± S.E.
RESULTS
E-box RESPONSE ELEMENTS IN THE αENaC PROMOTER CONTRIBUTE
TO ALDOSTERONE RESPONSE
Circadian clock proteins mediate their effects on gene expression
via binding to E-box response elements in the promoters of target
genes. Per1 does not contain a DNA binding domain, so it likely
binds target sites in DNA by forming a complex with a binding
partner. Per1 and CLOCK were both detected at an E-box from
the mouse αENaC promoter (Gumz et al., 2010). Promoter anal-
ysis of the human promoter was conducted using TF Search to
look for E-box sequences in close proximity to hormone response
elements (HREs). Two such sites were identified, E-box 1 and E-
box 2, located at positions −1116 and −116, respectively, relative
to the transcription start site (Figure 1A). To generate human
αENaC promoter constructs with defective E-boxes, mutations
were constructed at both sites. Mutated sequences were checked
with TF search to confirm disruption of the consensus site.
mpkCCDc14 cells were transfected with the wild-type αENaC
promoter-luciferase construct, the mutant mE-box 2 reporter
vector, or the mutant mE-box 1 plasmid. Twenty-four hours later,
cells were treated with vehicle or aldosterone for 24 h. Mutation of
either E-box element led to an approximate 75% overall decrease
in luciferase activity, indicating reduced promoter function in the
absence of either E-box (Figure 1B). The decreases were evident
in both basal and aldosterone-induced promoter activity.
Per1 ANDMR INTERACT WITH E-box RESPONSE ELEMENTS FROM THE
HUMAN αENaC PROMOTER IN AN ALDOSTERONE-DEPENDENT
MANNER
To further investigate Per1 and aldosterone-mediated regula-
tion of αENaC, a DAPA was performed. We hypothesized
that if the E-boxes in the αENaC promoter were required for
aldosterone action, MR may interact with these elements. 5′
biotinylated oligonucleuotide probes representing wild-type and
mutated human E-box 1 and E-box 2 were incubated with
nuclear extracts from mpkCCDc14 cells treated for 24 h with
either vehicle or aldosterone. MR was found to complex with the
E-box response elements in an aldosterone-dependent manner
(Figure 2, Lanes 1–4). Interaction of Per1 increased at both E-
boxes in aldosterone-treated cells, supporting the hypothesis that
these sites represent aldosterone-responsive circadian response
elements. CLOCK was found to bind to both E-boxes but was
not significantly increased under these conditions in the pres-
ence of aldosterone. Importantly, interaction of Per1, MR, and
CLOCK with E-box 1 and E-box 2 was abolished upon mutation
of the binding site (Figure 2, Lanes 5–8). Thus, the interaction
of MR and Per1 with the E-box response elements from the
human αENaC promoter appears to be aldosterone-dependent
and sequence specific.
ALDOSTERONE LEADS TO INCREASED OCCUPANCY OF Per1 AND MR
ON AN E-box IN THE αENaC PROMOTER IN mpKCCDC14 CELLS
To further corroborate our in vitro findings of the aldosterone-
dependent interactions of Per1 and MR on the E-box response
elements, ChIP experiments were conducted using mpkCCDc14
cells treated with vehicle or aldosterone for 24 h (Figure 3).
Aldosterone resulted in increased occupancy of RNA poly-
merase II on this region of the αENaC promoter, consistent
with increased transcription of the gene. Importantly, aldosterone
treatment resulted in increased MR and Per1 occupancy, consis-
tent with the in vitro DNA pull down experiments in Figure 2.
These ChIP results provide the first direct evidence for the pres-
ence of Per1 and MR in a region of the endogenous αENaC
promoter that includes an E-box in response to aldosterone.
DISCUSSION
Here we provide substantive mechanistic evidence for co-
regulation of the αENaC gene by Per1 and MR. The two
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FIGURE 1 | Mutation of E-box elements inhibits basal and
aldosterone-mediated αENaC promoter activity. (A) Cartoon of the
αENaC promoter indicating E-box sites that were mutated and nearby
hormone response elements (HRE) (not to scale). The position of
each E-box element and HRE relative to the transcription start site is
indicated. (B) Cells were transfected with the pRL renilla luciferase
and a plasmid containing the αENaC promoter or a mutated form,
cloned upstream of the firefly luciferase cDNA. E-box 1
(TCCAGCTGTC) at −1116, relative to the transcription start site was
mutated to mE-box 1 (TCCAGCTAGC) and E-box 2 (TTCACCTGGG)
at -116 was mutated to mE-box 2 (GGTACCTGGG). Cells were either
not treated (No Tx) or treated with vehicle or aldosterone (aldo) for
24 h. Data are presented as the mean ± standard error, n = 6,
∗∗p < 0.01 vs. α ENaC/luc + no treatment.
FIGURE 2 | Per1 and MR interact with E-boxes from the αENaC
promoter. Nuclear extracts from mpkCCDc14 cells treated with vehicle or
aldosterone were incubated with biotinylated probes from the human
wild-type (Lane 1–4) or mutated (Lane 5–8) E-box 1 (−1116) and human
E-box 2 (−116) to perform DAPA. Western blot analysis was performed
using anti-MR, anti-Per1 or anti-Clock. anti-Actin was used as a loading
control on supernatants. Data are representative of 3 independent
experiments. mE-box 1 and mE-box 2 represent mutated E-box probes
used as a negative control. Mutations made to these sequences exactly
match the E-box mutations made in Figure 1.
transcription factors activate in an aldosterone-dependent man-
ner. Promoter-luciferase assays, DAPA, and ChIP consistently
demonstrated a role for Per1 and E-box response elements in
the aldosterone-mediated regulation of αENaC. For the first time
it was shown that MR and Per1 both interact with canonical
E-box circadian response elements located within the 5′ regula-
tory region of the human αENaC promoter. ChIP analysis also
demonstrated that MR and Per1 are both present on a region of
FIGURE 3 | Aldosterone treatment leads to increased occupancy of
Per1 and MR on the αENaC promoter in mpkCCDc14 cells. Chromatin
immunoprecipitation experiments were performed using mpkCCDc14 cells
treated with either vehicle (ethanol) or 1μM aldosterone for 24 h.
Chromatin immuprecipitations were performed using anti-Per1 (Pierce),
anti-rMR1-18 1D5 (anti-MR) (DSHB), anti-Pol II (Santa Cruz), or rabbit IgG
(Bethyl) (negative control) antibodies. Endpoint PCR was performed using
primers flanking the previously determined E-box in the mouse αENaC
promoter. Bands were quantitated using densitometry, which was
performed using ImageJ (rsbweb.nih.gov/ij). Signal strength was
normalized to the relevant vehicle or aldosterone treated input control.
N = 3 for MR, Per1, and IgG, n = 2 for RNA pol. Values are represented as
the mean ± SEM. ∗p < 0.05, Aldosterone vs. Vehicle.
the endogenous mouse αENaC promoter containing a canonical
E-box, providing the first direct evidence of Per1 occupancy on
the αENaC promoter.
It is important to note that a putative HRE is located within
the ChIP amplicon and in close proximity to the E-box (−770
for the HRE, −689 for the E-box). As shown above (Figure 1A),
several HREs are located within close proximity to the E-boxes in
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the human αENaC promoter. Because the E-boxes and apparent
HREs are so close together, ChIP alone does not allow unambigu-
ous resolution of the MR binding site in this region. However,
evidence from the DAPA experiments supports a model in which
MR and Per1 interact with the E-box response element of the
αENaC gene promoter. The E-boxes appear to be critical for the
aldosterone induction of αENaC in collecting duct cells.
It is likely that Per1 is associating with other components of
the canonical clock complex such as CLOCK and BMAL1 as the
Per1 protein does not contain an inherent DNA binding domain
(Kucera et al., 2012). In this study, we demonstrate CLOCK and
Per1 binding to the same E-boxes in our DAPA experiments.
However, further experiments are needed to clarify the exact
mechanism of this interaction and to identify the specific proteins
Per1 associates with in order to interact with the E-box response
elements in the αENaC promoter.
E-boxes have previously been implicated as transcriptional tar-
gets for glucocorticoid action (Singletary et al., 2008). MR is
highly homologous to glucocorticoid receptor (GR) and both
receptors are ligand-dependent transcription factors (Arriza et al.,
1987; Kohn et al., 2012). MR and GR share 94% primary sequence
homology in the DNA binding domain, and both receptors share
the same HREs in several genes, including αENaC (Arriza et al.,
1987; Chen, 1999; Mick et al., 2001). Both nuclear receptors con-
tribute to the aldosterone-mediated induction of the Per1 gene
(Gumz et al., 2003, 2009). This result is consistent with previ-
ous findings that both Per1 and Per2 contribute to coordinate
circadian control of other metabolic pathways in peripheral tis-
sues via nuclear receptor signaling pathways (Albrecht et al., 2001;
Schmutz et al., 2010). Lamia et al. have shown that other circadian
clock proteins, Cry1 and Cry2, can interact with the GR, bind to
the glucocorticoid response element in the phosphoenolpyruvate
carboxykinase 1 promoter, and subsequently repress GR action
(Lamia et al., 2011). These earlier studies provided precedent for
coordinate action of MR and Per1 on transcriptional regulation
of αENaC.
The circadian clock plays an important role in the con-
trol of BP and renal function (Richards and Gumz, 2013).
CLOCK KO mice have lower BP, dysregulated sodium excre-
tion (Zuber et al., 2009) and the loss of circadian expression
of plasma aldosterone levels (Nikolaeva et al., 2012). BMAL1
KO mice exhibit reduced BP during the active phase (Curtis
et al., 2007). Cry1/Cry2 KO mice exhibit salt sensitive hyper-
tension due to an up-regulation in the aldosterone synthesis
enzyme 3-β-dehydrogenase-isomerase leading to increased aldos-
terone synthesis and high aldosterone levels (Doi et al., 2010).
Both the CLOCK KO and Cry1/Cry2 KO phenotypes and their
dysregulated aldosterone levels provide additional evidence of a
connection between the circadian clock and aldosterone signal-
ing. Together with our finding that Per1 is an early aldosterone
target (Gumz et al., 2003), the present study demonstrates that
MR and Per1 interact with E-boxes in the αENaC promoter. These
data provide additional evidence for the role of the circadian clock
in aldosterone signaling. The coordinated action of MR and Per1
may suggest a previously unrecognized mechanism by which the
circadian clock modulates physiological rhythms and aldosterone
signaling.
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